Osäkert om Sverige har vad som krävs

Framtidens sjukvård ligger i gränssnittet mellan medicin och it, enligt en rapport från Life Science Foresight Institute i Lund. Men det är osäkert om svensk industri har tillräckligt med resurser för att vara med i matchen....

Nya EU-regler påverkar life science-branschen

Stora regulatoriska förändringar på gång i EU.

Top modern lab to Sahlgrenska

The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.

Seminar program Biotech Forum

Here is the entire seminar program at Biotech Forum September 28-29th

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

Academy for a new turn at work

Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.

Take off for this year's fair

More visitors than previously were preregistered when Scanlab and Biotech Forum opened today. But the future of the exhibitions and their design is uncertain.

Life science in Stockholm

Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.

New member to Active board

The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...

Polymer guru new dean at DTU

The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.

New CEO to Medivir

The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.

Finnish-Dutch engineering cooperation continues

The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.

EU grants project on toxicity of nanomaterials

A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...

Focusing on Medicon Valley

Copenhagen Capacity and Invest in Skåne are hosting a seminar to promote the geographical area known as Medicon Valley. Some of the 350 life science companies f...

Trögt för medtech

En svag tillväxt, färre men större förvärv och rekordmånga börsnoteringar är några av fynden i konsultbolaget EY:s årliga sammanställning av medtechbranschen.

A platform for dialogue

As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Viktigt välja rätt bolagsnamn

Life science-branschen är generellt sett sämre än andra sektorer på att namnge sina bolag enligt Mats Dafnäs, varumärkesstrateg på kommunikationsbyrån Zellout.

LEO Pharma - International Clinical Trial Manager

Glucose facilitates the use of indigo

The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...

Regelkrångel hindrar industrin

42 procent av läkemedelsindustrin menar att regler och restriktioner är det största hotet mot framgångar på den svenska läkemedelsmarknaden.